PIXID Continues European Expansion with Acquisition of Dutch Staffing CRM Supplier Carerix
Adding a leading supplier for CRM and ATS systems to its ranks allows PIXID to reinforce its expertise, enhance its service offering and strengthen the value chain offered to the temporary employment sector.
The purchase also means PIXID can now add a presence in Benelux to its existing offices in France, in the UK (since its acquisition of The Internet Corporation in 2017) and its operations in Germany.
A complete online software solution for recruitment and staffing agencies, Carerix is currently helping more than 10,000 users every day. It has a presence in 17 countries due to high-profile relationships with major customers including Randstad, Adecco, Manpower, T-Groep and DPA.
Carerix has a multi-level partnership programme and an ecosystem which allows for a tailored offering and broader promotion of its products among specific target groups. This tallies with PIXID’s approach to enable clients of all sizes to efficiently manage their temporary workers via a simple, scalable and cost-effective platform.
PIXID’s proprietary technology is currently responsible for filling one in four temporary positions in France, where it has powered the temporary staff market. The acquisition of Carerix further establishes it as a well-known digital platform for the management of temporary workforces throughout Europe. The acquisition is consistent with PIXID’s strategy of utilising its scale to grow the core flexible workforce management business stream and adding other staffing and recruitment solutions into the overall portfolio.
In 2017, PIXID generated solid revenue growth of 23% and Management is expecting to record revenues of around €25m in 2018. Pixid now covers more than 90% of the temporary employment market in France and has two million workers registered in its database.
Etienne Colella, President of PIXID SAS, commented: “Since 2004 we’ve continued to grow to the point where we now represent a significant part of the temporary employment market in France. But our ambitions are much wider than that and we are now adding Benelux to our existing presence in France, the UK and Germany. Each country has its own idiosyncrasies and we were keen to choose the right partner with a strong market share and dynamic innovation strategy – qualities that Carerix perfectly embodies. The acquisition is the first phase of our introduction to this new region, known to be a mature and vibrant HR marketplace. We are confident that our combined solutions will make a significant contribution to helping those sourcing and placing temporary workers to reinvent their way of working and realise efficiencies.”
Reinald Snik, CEO of Carerix, said: “As with PIXID, our objective is to transcend borders and we already have a presence in most European countries thanks to our relationships with key customers. Becoming part of the PIXID Group will give us greater scale to achieve these ambitions, while retaining our brand in our home market. The acquisition is a real innovation opportunity which will be mutually beneficial for both parties; our existing customers and to open up and expand other staffing markets throughout Europe.”
Jean-Michel Beghin, Managing Partner at Keensight Capital, said: “We are delighted to support Etienne Colella in PIXID’s new development stage, further to last year’s successful integration of The Internet Corporation in the UK. We had identified Carerix as it complements PIXID’s service, for its solid growth profile based on SaaS model and led by a talented management team, as well as for its highly appreciated innovation capabilities. Its strong foothold in the Netherlands and throughout Benelux will clearly contribute to strengthen PIXID's positioning as a leading European digital platform for the management of flexible workforce.”
Created in 2004, PIXID is the leading VMS in France to offer a complete SAAS application compliant with the many aspects of French regulation for providing and using temporary staff. PIXID’s platform enables clients of all sizes to efficiently manage its temporary workers via a simple, scalable and cost-effective platform. The PIXID offering manages recruiters, suppliers and employment contracts while helping to ensure that its clients are compliant with the latest employment regulations. More than 100,000 client locations are daily connected through PIXID to lower their costs and work more efficiently with their suppliers on-line. Today, the company deals with 4,000,000 contracts. Very innovative services, like the electronic signature of HR contracts are available to customers ranging from large accounts to SMB.
PIXID works in close partnership with the French Ministry of Labour, Employment, Vocational Training and Social Dialogue in its heartland and has established working relationships with The Recruitment & Employment Confederation and The Association of Professional Staffing Companies since its foray into the UK market.
For more information, visit https://www.pixid.fr/en and follow @PIXID_Group
Carerix supplies state-of-the-art recruitment and staffing solutions that help corporate recruiters and intermediaries to find the best match. The solutions are hosted in a SaaS model and supplied via secure data centres. Carerix was founded in 2004 and currently has more than 70 employees and over 720 clients, including (divisions of) Randstad, USG, Adecco, DPA, Manpower and specialised intermediaries in ICT, oil & gas, finance and service industries. Carerix serves over 10,000 users every day, in 17 different countries, and collaborates with various strategic partners in a strong eco-system. Carerix is located in the Cornerstone Business Park at Rotterdam The Hague Airport.
For more information, visit www.carerix.com
About Keensight Capital
Keensight Capital, one of the leading European Growth Private Equity firms, is committed to supporting entrepreneurs as they implement their growth strategies. For almost 20 years now, our team of seasoned professionals have leveraged their knowledge in investment and growth industries to invest for the long term in profitable companies with high growth potential and revenues in the range of €15 million to €250 million.
Drawing on our expertise in a variety of sectors including Internet/Media, Information Technology, Healthcare and Services, we identify the best investment opportunities in Europe and work closely with management teams to develop and achieve their strategic vision.
For more information, visit www.keensightcapital.com
Mark Walter & Barney McCarthy
+ 44 207 457 2020
For Keensight Capital
Anne de Bonnefon
+33 1 83 79 87 37
Citigate Dewe Rogerson
+33 6 64 32 81 75
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Schlumberger Announces Fourth-Quarter and Full-Year 2018 Results Conference Call16.11.2018 21:00 | Tiedote
Schlumberger Limited (NYSE:SLB) will hold a conference call on January 18, 2019 to discuss the results for the fourth quarter and full year ending December 31, 2018. The conference call is scheduled to begin at 8:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 288-8967 within North America or +1 (612) 333-4911 outside of North America approximately 10 minutes prior to the start of the call, and ask for the “Schlumberger Earnings Conference Call.” A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until February 18, 2019, and can be accessed by dialing +1 (800)
Visa Strengthens Commitment to Growing Digital Payments in India16.11.2018 17:33 | Tiedote
Visa (NYSE: V) today announced a minority investment in BillDesk, a leading platform for online payments and bill payments in India. Visa’s investment and collaboration will help BillDesk develop new product lines for its payments and loyalty businesses and also expand its footprint into other geographies. The investment will be subject to necessary statutory approvals and is expected to have no direct bearing on Visa’s existing Indian business. “As a leading payments player in India, BillDesk has been a long time business partner to Visa. Having worked with BillDesk’s founders over the years, the Visa leadership has been consistently impressed with their vision, market knowledge and execution capabilities, as well as alignment on values. This investment further reinforces our long-term commitment to India’s digital payments growth story,” said Asia Pacific regional president, Chris Clark. “We are truly excited by this investment from the world's largest global payment network, Visa. W
Guidewire Enhances PartnerConnect Consulting Program with Addition of Product and Regional Specializations16.11.2018 16:55 | Tiedote
Guidewire Software, Inc. (NYSE: GWRE), provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced the addition of specializations to its PartnerConnect Consulting program. Specializations have been added to aid insurance companies in selecting the best partner to lead or staff their Guidewire projects. Guidewire unveiled new specializations, including two which have been successfully piloted earlier this year. “Our customers will now have more clarity and information as to which partners have the proven capabilities in their chosen product and region,” said Lisa Walsh, vice president, Alliances, Guidewire Software. “Adding these specializations will also allow us to have more insight into a partner’s performance and competencies.” To earn a specialization, partners need to demonstrate skills, knowledge, and competency in a specific Guidewire product or solution by certifying staff at multiple levels (specialist and professional) through Guidewire’
Janssen receives positive CHMP opinion for ERLEADA™ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer who are at high risk of developing metastatic disease16.11.2018 16:15 | Tiedote
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for apalutamide, a next generation oral androgen receptor inhibitor for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.2 The CHMP’s positive opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the use of apalutamide. The CHMP’s positive opinion is based on data from the pivotal SPARTAN Phase 3 clinical study which assessed the safety and efficacy of apalutamide versus placebo in patients with nmCRPC who have a rapidly rising prostate specific antigen (PSA) level despite receiving continuous androgen deprivation therapy (ADT). The SPARTAN clinical study showed that apalutamide, when added to ADT, significantly reduced the risk
Vertex Receives European CHMP Positive Opinion for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease16.11.2018 15:57 | Tiedote
Vertex Pharmaceuticals (Europe) Limited today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, lumacaftor/ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF for patients aged 2 to 5 years old who have two copies of the F508del mutation. “Cystic fibrosis is a chronic, progressive disease and it is important to treat early to ensure the best possible outcomes for patients,” said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. “Today’s announcement brings us one step cl
Dimension Data Global Delivery Centre (GDC) in Prague wins the ABSL 2018 Diamond Award for Business Innovation16.11.2018 11:00 | Tiedote
Dimension Data, the USD 8 billion global technology integrator and managed services provider, today announced that its Global Delivery Centre (GDC) in Prague has won the 2018 ABSL Diamond award for Business Innovation. The main purpose of this centre is to provide innovative, global service delivery capabilities and deep technical expertise to support our clients. The ABSL Diamond awards recognise companies that implement innovative projects, enhancing their business and strengthening the position of the business services sector. Every year, the aim is to identify successful activities in this sector and promote best practices, ultimately encouraging and inspiring others to follow suit. The ABSL celebrates initiatives that push business services forward and stand out as exemplary projects. Bill Padfield, Group Chief Operating Officer for Transformation and Services at Dimension Data, said: “Winning another award for our Support Services is a fantastic achievement. This time the ABSL Di
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme